Skip to main content
SpringerLink
Log in

Pneumonia in cancer patients

  • Chapter
Infectious Complications of Cancer

Part of the book series: Cancer Treatment and Research ((CTAR,volume 79))

Abstract

Pneumonia is one of the most common and life-threatening infections occurring among patients with cancer [1–3]. Among neutropenic patients hospitalized at the M.D. Anderson Cancer Center (MDACC) between 1978 and 1985, pneumonia accounted for one quarter of the 1329 febrile episodes caused by documented infections [4]. A pathogen was identified in only 34 percent of these pneumonias, and the overall response rate was only 45 percent.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rosenow EC III, Wilson WR, Cockerill FR III. 1985. Pulmonary disease in the immunocompromised host. Mayo Clin Proc 60:473–487, 610–631.

    PubMed  Google Scholar 

  2. Levine SJ. 1992. An approach to the diagnosis of pulmonary infections in immunosuppressed patients. Semin Respir Infect 7:81–95.

    PubMed  CAS  Google Scholar 

  3. Rubin RH, Greene R. 1987. Etiology and management of the compromised patient with fever and pulmonary infiltrates. In: Rubin RH, Young LS, eds. Clinical Approach to Infection in the Compromised Host. New York: Plenum, pp 131–164.

    Google Scholar 

  4. Bodey GP. 1993. Empirical antibiotic therapy for fever in neutropenic patients. Clin Infect Dis 17(Suppl 2):S378–S384.

    Article  PubMed  Google Scholar 

  5. Sickles EA, Greene WH, Wiernik PH. 1975. Clinical presentation of infection of granulocytopenic patients. Arch Intern Med 135:715–719.

    Article  PubMed  CAS  Google Scholar 

  6. Bodey GP, Powell RD, Hersh EM, Yeterian A, Freireich EJ. 1966. Pulmonary complications of acute leukemia. Cancer 19:781–793.

    Article  PubMed  CAS  Google Scholar 

  7. Chang H-Y, Rodriguez V, Narboni G, Bodey GP, Luna MA, Freireich EJ. 1976. Causes of death in adults with leukemia. Medicine 55:259–268.

    Article  PubMed  CAS  Google Scholar 

  8. Valdivieso M, Gil-Extremera B, Zornoza J, Rodriguez V, Bodey GP. 1977. Gram-negative bacil-lary pneumonia in the compromised host. Medicine 56:241–253.

    Article  PubMed  CAS  Google Scholar 

  9. Singer C, Kaplan MH, Armstrong D. 1977. Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med 62:731–743.

    Article  PubMed  CAS  Google Scholar 

  10. Bodey GP, Rodriguez V, Chang H-Y, Narboni G. 1978. Fever and infection in leukemic patients: A study of 494 consecutive patients. Cancer 41:1610–1622.

    Article  PubMed  CAS  Google Scholar 

  11. Whimbey E, Kiehn TE, Brannon P, Blevins A, Armstrong D. 1987. Bacteremia and fungemia in patients with neoplastic disease. Am J Med 82:723–730.

    Article  PubMed  CAS  Google Scholar 

  12. Bodey GP, Jadeja L, Elting L. 1985. Pseudomonas bacteremia. Retrospective analysis of 410 episodes. Arch Intern Med 145:1621–1629.

    Article  PubMed  CAS  Google Scholar 

  13. Bodey GP, Elting L, Kassamali H, Lim BP. 1986. Escherichia coli bacteremia in cancer patients. Am J Med 81: 85–95.

    Article  PubMed  CAS  Google Scholar 

  14. Bodey GP, Elting LS, Rodriguez S, Hernandez M. 1989. Klebsiella bacteremia. A 10-year review in a cancer institution. Cancer 64:2368–2376.

    Article  PubMed  CAS  Google Scholar 

  15. Elting LS, Bodey GP. 1990. Septicemia due to Xanthomonas species and non-aeruginosa Pseudomonas species: Increasing incidence of catheter-related infections. Medicine 69:296–306.

    Article  PubMed  CAS  Google Scholar 

  16. Khardori N, Elting L, Wong E, Schable B, Bodey GP. 1990. Nosocomial infections due to Xanthomonas maltophilia (Pseudomonas maltophilia) in patients with cancer. Rev Infect Dis 12:997–1003.

    Article  PubMed  CAS  Google Scholar 

  17. Bodey GP, Elting LS, Rodriguez S. 1991. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis 13:550–558.

    Article  PubMed  CAS  Google Scholar 

  18. Samonis G, Anaissie E, Elting L, Bodey GP. 1991. Review of Citrobacter bacteremia in cancer patients over a sixteen-year period. Eur J Clin Microbiol Infect Dis 10:279–285.

    Article  Google Scholar 

  19. Aoun M, van der Auwera P, Devleeshouwer C, Daneau D, Seraj N, Meunier F, Gerain J. 1992. Bacteraemia caused by non-aeruginosa Pseudomonas species in a cancer center. J Hosp Infect 22:307–316.

    Article  PubMed  CAS  Google Scholar 

  20. Yamagishi Y, Fujita J, Takigawa K, Negayama K, Nakazawa T, Takahara J. 1993. Clinical features of Pseudomonas cepacia pneumonia in an epidemic among immunocompromised patients. Chest 103:1706–1709.

    Article  PubMed  CAS  Google Scholar 

  21. Awada A, van der Auwera P, Meunier F, Daneau D, Klastersky J. 1992. Streptococcal and enterococcal bacteremia in patients with cancer. Clin Infect Dis 15:33–48.

    Article  PubMed  CAS  Google Scholar 

  22. Elting LS, Bodey GP, Keefe BH. 1992. Septicemia and shock syndrome due to viridans streptococci: A case-control study of predisposing factors. Clin Infect Dis 14:1201–1207.

    Article  PubMed  CAS  Google Scholar 

  23. Bodey GP, Buckley M, Sathe YS, Freireich EJ. 1966. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–339.

    PubMed  CAS  Google Scholar 

  24. Klastersky J, Henri A, Hensgens C, et al. 1974. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin. JAMA 227:45–48.

    Article  PubMed  CAS  Google Scholar 

  25. Klastersky J, Hensgens C, Debusscher L. 1975. Empiric therapy for cancer patients: Comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin and cephalothin-tobramycin. Antimicrob Agents Chemother 640–645.

    Google Scholar 

  26. Schimpff SC. 1977. Therapy of infection in patients with granulocytopenia. Med Clin North Am 61:1101–1108.

    PubMed  CAS  Google Scholar 

  27. Schimpff SC, Aisner J. 1978. Empiric antibiotic therapy. Cancer Treat Rep 62:673–680.

    PubMed  CAS  Google Scholar 

  28. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG, Levine AS, Deisseroth AB, Glaubiger DL, Maclowry JD, Magrath IT, Poplack DG, Simon RM. 1979. Duration of empiric antibiotic therapy in granulocytopenic patients with cancer. Am J Med 67:194–200.

    Article  PubMed  CAS  Google Scholar 

  29. Love LJ, Schimpff SC, Schiffer CA, Wiernik PH. 1980. Improved prognosis for ganulocytopenia patients with gram-negative bacteremia. Am J Med 68:643–648.

    Article  PubMed  CAS  Google Scholar 

  30. De Jongh CA, Joshi JH, Thompson BW, et al. 1986. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. Am J Med 80(Suppl 5C):101–111.

    PubMed  Google Scholar 

  31. Klastersky J, Glauser MP, Schimpff SC, Zinner SH, Gaya H. 1986. European Organization for Research in the Treatment of Cancer Antimicrobial Therapy Project Group. Prospective randomized comparision of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother 29:263–270.

    PubMed  CAS  Google Scholar 

  32. Klastersky J, Zinner SH, Calandra T, et al. 1988. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: Lessons from four EORTC trials. Eur J Cancer Oncol 24(Suppl 1):S35–S45.

    Google Scholar 

  33. Bodey GP. 1989. Evolution of antibiotic therapy for infection in neutropenic patients: Studies at M.D. Anderson Hospital. Rev Infect Dis 11(Suppl 7):S1582–S1590.

    Article  PubMed  Google Scholar 

  34. Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, Schimpff SC, Shenep JL, Wade JC, Young LS, Yow MD. 1990. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 161:381–396.

    Article  PubMed  CAS  Google Scholar 

  35. Wade J. 1993. Management of infection in patients with acute leukemia. Hematol Oncol Clin North Am 7:293–315.

    PubMed  CAS  Google Scholar 

  36. Klastersky J, Cappel R, Daneau D. 1972. Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother 2:470–475.

    PubMed  CAS  Google Scholar 

  37. Klastersky J, Meunier-Carpentier F, Prevost JM. 1977. Significance of antimicrobial synergism for the outcome of gram negative sepsis. Am J Med Sci 273:157–164.

    Article  PubMed  CAS  Google Scholar 

  38. Pizzo PA, Hathorn JW, Hiemenz J, et al. 1986. A randomized trial comparing ceftazidine alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 315:552–558.

    Article  PubMed  CAS  Google Scholar 

  39. Bodey GP, Middleman E, Umsawasdi T, Rodriguez V. 1972. Infections in cancer patients: Results with gentamicin sulfate therapy. Cancer 29:1697–1701.

    Article  PubMed  CAS  Google Scholar 

  40. Valdivieso M, Horikoshi N, Rodriguez V, Bodey GP. 1974. Therapeutic trials with tobramycin. Am J Med Sci 268:149–156.

    Article  PubMed  CAS  Google Scholar 

  41. Shenep JL, Hughes WT, Roberson PK, Blankenship KR, Baker DK Jr, Meyer WH, Gigliotti F, Sixbey JW, Santana VM, Feldman S, et al. 1988. Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neturopenic children with cancer. N Engl J Med 1988:1053–1058.

    Google Scholar 

  42. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinial Trials Group. 1991. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. J Infect Dis 163:951–958.

    Article  Google Scholar 

  43. Ching WTW, Meyer RD. 1987. Legionella infections. Infect Dis Clin North Am 1:595–614.

    PubMed  CAS  Google Scholar 

  44. England AC III, Fraser DW, Plikaytis BD, Tsai TF, Storch G, Broome CV. 1981. Sporadic legionellosis in the United States: The first thousand cases. Ann Intern Med 94:164–170.

    PubMed  Google Scholar 

  45. Kugler JW, Armitage JO, Helms CM, Klassen LW, Goeken NE, Ahmann GB, Gingrich RD, Johnson W, Gilchrist MJR. 1983. Nosocomial Legionnaires’ disease: Occurrence in recipients of bone marrow transplants. Am J Med 74:281–288.

    Article  PubMed  CAS  Google Scholar 

  46. Schwebke JR, Hackman R, Bowden R. 1990. Pneumonia due to Legionella micdadei in bone marrow transplant recipients. Rev Infect Dis 12:824–827.

    Article  PubMed  CAS  Google Scholar 

  47. Kirby BD, Snyder KM, Meyer RD, Finegold SM. 1989. Legionnaires’ disease: report of sixty-five nosocomially acquired cases and review of the literature. Medicine 59:188–205.

    Google Scholar 

  48. Edelstein PH. 1993. Legionnaires’ disease. Clin Infect Dis 16:741–749.

    Article  PubMed  CAS  Google Scholar 

  49. Young LS, Armstrong D, Blevins A, Lieberman P. 1971. Nocardia asteroides infection complicating neoplastic disease. Am J Med 50:356–367.

    Article  PubMed  CAS  Google Scholar 

  50. Simpson GL, Stinson EB, Egger MJ, Remington JS. 1981. Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis 3:492–507.

    Article  PubMed  CAS  Google Scholar 

  51. Stevens DA, Pier AC, Beaman BL, Morozumi PA, Lovett IS, Houang ET. 1981. Laboratory evaluation of an outbreak of nocardiosis in immunocompromised hosts. Am J Med 71:928–934.

    Article  PubMed  CAS  Google Scholar 

  52. Smego RA, Gallis HA. 1984. The clinical spectrum of Nocardia brasiliensis infection in the United States. Rev Infect Dis 6:164–179.

    Article  PubMed  Google Scholar 

  53. Berkey P, Bodey GP. 1989. Nocardial infection in patients with neoplastic disease. Rev Infect Dis 11:407–412.

    Article  PubMed  CAS  Google Scholar 

  54. Wilson JP, Turner HR, Kirchner KA, Chapman SW. 1989. Nocardial infections in renal transplant recipients. Medicine 68:38–55.

    Article  PubMed  CAS  Google Scholar 

  55. Wallace RJ, Septimus EJ, Williams TW, Conklin RH, Satterwhite TK, Bushby MB, Hollowell DC. 1982. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 4:315–323.

    Article  PubMed  CAS  Google Scholar 

  56. Smego RA, Moeller MB, Gallis HA. 1983. Trimethoprim-sulfamethoxazole therapy for Nocardia infections. Arch Intern Med 143:711–718.

    Article  PubMed  Google Scholar 

  57. Peterson EA, Nash ML, Mammana RB, Copeland JG. 1983. Minocycline treatment of pulmonary nocardiosis. JAMA 250:930–932.

    Article  Google Scholar 

  58. Kaplan MH, Armstrong D, Rosen P. 1974. Tuberculosis complicating neoplastic disease: A review of 201 cases. Cancer 33:850–858.

    Article  PubMed  CAS  Google Scholar 

  59. Feld R, Bodey GP, Gröschel D. 1976. Mycobacteriosis in patients with malignant disease. Arch Intern Med 136:67–70.

    Article  PubMed  CAS  Google Scholar 

  60. Ortbals DW, Marr JJ. 1978. A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy. Am Rev Respir Dis 117:39–45.

    PubMed  CAS  Google Scholar 

  61. Millar JW, Hörne NW. 1979. Tuberculosis in immunosuppressed patients. Lancet 1176–1178.

    Google Scholar 

  62. Kurzrock R, Zander A, Vellekoop L, Kanjia M, Luna M, Dicke K. 1984. Mycobacterial pulmonary infections after allogeneic bone marrow transplantation. Am J Med 77:35–40.

    Article  PubMed  CAS  Google Scholar 

  63. Bennett C, Vardiman J, Golomb H. 1986. Disseminated atypical mycobacterial infection in patients with hairy cell leukemia. Am J Med 80:891–896.

    Article  PubMed  CAS  Google Scholar 

  64. Centers for Disease Control. 1992. National action plan to combat multi-drug resistant tuberculosis. MMWR 41(RR-11):l–48.

    Google Scholar 

  65. Kiehn TE, White M, Pursell KJ et al. 1993. A cluster of four cases of Mycobacterium haemophilum infection. Eur J Clin Microbiol Infect Dis 12:114–118.

    Article  PubMed  CAS  Google Scholar 

  66. Young LS. 1993. Mycobacterial diseases and the compromised host. Clin Infect Dis 17(Suppl 2):436–441.

    Article  Google Scholar 

  67. Johnson L, Kiehn TE. 1994. Mycobacterium avium complex infections in cancer patients. Infect Med 184–186.

    Google Scholar 

  68. Myerwitz RL, Pazin GJ, Allen CM. 1977. Disseminated candidiasis. Changes in incidence, underlying diseases and pathology. Am J Clin Pathol 68:29–38.

    Google Scholar 

  69. Maksymiuk AW, Thongprasert S, Hopfer R, Luna M, Fainstein V, Bodey GP. 1984. Systemic candidiasis in cancer patients. Am J Med 77:20–27.

    PubMed  CAS  Google Scholar 

  70. Haron E, Vartivarian S, Anaissie E, Dekmezian R, Bodey GP. 1993. Primary Candida pneumonia—Experience at a large cancer center and review of the literature. Medicine 72:137–142.

    PubMed  CAS  Google Scholar 

  71. Saito H, Anaissie EJ, Morice RC, Dekmezian R, Bodey GP. 1988. Bronchoalveolar lavage in the diagnosis of pulmonary infiltrates in patients with acute leukemia. Chest 94:745–749.

    Article  PubMed  CAS  Google Scholar 

  72. Anaissie EJ, Darouiche R, Mera J, Gentry L, Abi-Said D, Bodey GP. 1993. A prospective randomized multicenter study comparing fluconazole to amphotericin B for nosocomial candidiasis. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October 1993.

    Google Scholar 

  73. Zimmerman LE, Rappaport H. 1954. Occurrence of cryptococcosis in patients with malignant disease of the reticuloendothelial system. Am J Clin Pathol 24: 1050–1057.

    PubMed  CAS  Google Scholar 

  74. Libshitz HI, Pagoni J. 1981. Aspergillosis and mucormycosis: Two types of opportunistic fungal pneumonia. Radiology 140:303–306.

    Google Scholar 

  75. Yu VL, Muder RR, Poorsattar A. 1986. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis: Results from a three-year prospective study. Am J Med 81:249–254.

    Article  PubMed  CAS  Google Scholar 

  76. Karp JE, Burch PA, Merz WG, Levey WG. 1988. An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. Am J Med 85:203–206.

    Article  PubMed  CAS  Google Scholar 

  77. Rabodonirina M, Piens MA, Monier MF, Gueho E, Fiere D, Mojon M. 1994. Fusarium infections in immunocompromised patients: Case reports and literature review. Eur J Clin Microbiol Infect Dis 13:152–161.

    Article  PubMed  CAS  Google Scholar 

  78. Hoy J, Hsu KC, Rolston K, Hopfer RL, Luna M, Bodey GP. 1986. Trichosporon beigelii infection: A review. Rev Infect Dis 8:959–967.

    Article  PubMed  CAS  Google Scholar 

  79. Meyers JD, Flournoy N, Thomas ED. 1982. Nonbacterial pneumonia after allogeneic marrow transplantation: A review of ten years’ experience. Rev Infect Dis 4:1119–1132.

    Article  PubMed  CAS  Google Scholar 

  80. Ljungman P, Gleaves CA, Meyers JD. 1989. Respiratory virus infection in immunocompromised patients. Bone Marrow Transplant 4:35–40.

    PubMed  CAS  Google Scholar 

  81. Whimbey E, Bodey GP. 1992. Viral pneumonia in the immunocompromised adult with neoplastic disease: The role of common community respiratory viruses. Semin Respir Infect 7:122–131.

    PubMed  CAS  Google Scholar 

  82. Balfour HH, Chace BA, Stapleton JT, Simmons RL, Fryd DS. 1989. A randomized placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320:1381–1387.

    Article  PubMed  Google Scholar 

  83. Goodrich JM, Bowden R, Kellar C, Meyers JD. 1993. Prevention of cytomegalovirus disease after allogeneic marrow transplant by ganciclovir prophylaxis. Ann Intern Med 117:173–178.

    Google Scholar 

  84. Winston DJ, Ho WG, Bartoni K, et al. 1993. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic marrow transplants. Ann Intern Med 117:179–184.

    Google Scholar 

  85. Goodrich J, Mori M, Gleaves C, et al. 1991. Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic marrow transplant. N Engl J Med 325:1601–1607.

    Article  PubMed  CAS  Google Scholar 

  86. Schmidt GM, Horak DA, Niland JC, et al. 1991. A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants. N Engl J Med 324:1005–1011.

    Article  PubMed  CAS  Google Scholar 

  87. Reed EC, Bowden RA, Dandliker PS, Lilleby KE, Meyers JD. 1988. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann Intern Med 109:783–788.

    PubMed  CAS  Google Scholar 

  88. Emanuel D, Cunningham I, Jules-Elysee K, et al. 1988. Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. Ann Intern Med 109:777–782.

    PubMed  CAS  Google Scholar 

  89. Mera JR, Whimbey E, Luna M, Preti A, Elting L, Vartivarian S, Williams TW, Bodey GP. 1992. Incidence of cytomegalovirus (CMV) pneumonia in adult non-transplant cancer patients: Review of 3549 autopsies from 1964–1990. In: Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim, California, 1992.

    Google Scholar 

  90. 90. Ramsey PG, Fife KH, Hackman RC, Meyers JD, Corey L. 1982. Herpes simplex pneumonia. Ann Intern Med 97:813–820.

    PubMed  CAS  Google Scholar 

  91. Wade JC, Newton B, Flournoy N, Meyers JD. 1984. Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. Ann Intern Med 100:823–828.

    PubMed  CAS  Google Scholar 

  92. Feldman S, Hughes WT, Daniel CB. 1975. Varicella in children with cancer: Seventy-seven cases. Pediatrics 56:366–397.

    Google Scholar 

  93. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. 1985. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 152:1172–1181.

    Article  PubMed  CAS  Google Scholar 

  94. Straus SE, Ostrove JM, Inchauspe G, et al. 1988. Varicella-zoster virus infections. Ann Intern Med 108:221–227.

    PubMed  CAS  Google Scholar 

  95. Balfour HH. 1991. Varicella-zoster virus infections in the immunocompromised host. Scand J Infect Dis (Suppl 78):69–74.

    Google Scholar 

  96. Rigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. 1991. Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338:147–149.

    Article  Google Scholar 

  97. Cone RW, Hackman RC, Huang MW, et al. 1993. Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329:156–161.

    Article  PubMed  CAS  Google Scholar 

  98. Brief Report. 1994. Fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow transplant recipient. N Engl J Med 330:1356–1360.

    Article  Google Scholar 

  99. Aschan O, Ringden O, Ljungman P, Andersson J, Lewensohn-Fuchs L, Forsgren M. 1989. Influenza B in transplant patients. Scand J Infect Dis 21:349–350.

    Article  PubMed  CAS  Google Scholar 

  100. Ljungman P, Andersson J, Aschan J, Barkholt L, Ehrnst A, Johansson M, Weiland O. 1993. Influenza A in immunocompromised patients. Clin Infect Dis 17:244–247.

    Article  PubMed  CAS  Google Scholar 

  101. Whimbey E, Elting LS, Couch RB, Lo W, Williams L, Champlin RE, Bodey GP. 1994. Influenza A virus infection among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 13:437–440.

    PubMed  CAS  Google Scholar 

  102. Elting LS, Whimbey E, Lo W, Couch R, Andreeff M, Bodey GP, Epidemiology of influenza A virus infection in patients with acute or chronic leukemia. Support Care Cancer 3:198–202, 1995.

    Article  PubMed  CAS  Google Scholar 

  103. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. 1993. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur Clin Microbiol Infect Dis 12:778–782.

    Article  CAS  Google Scholar 

  104. Englund JA, Sullivan CJ, Jordan CM, Dehner, LP, Vercellotti M, Balfour HH. 1988. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 109:203–208.

    PubMed  CAS  Google Scholar 

  105. Hertz MI, Englund JA, Snover D, Bitterman PB, McGlave PB. 1989. Respiratory syncytial virus-indued acute lung injury in adult patients with bone marrow transplants: A clinical approach and review of the literature. Medicine 68:269–281.

    Article  PubMed  CAS  Google Scholar 

  106. Harrington RD, Hooton RD, Hackman RC, Storch GA, Osborne B, Gleaves CA, Benson A, Meyers JD. 1992. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 165:987–993.

    Article  PubMed  CAS  Google Scholar 

  107. Whimbey E, Champlin RE, Englund JA, Mirza NQ, Piedra PA, Goodrich JM, Przepiorka D, Luna MA, Morice RC, Neumann JL, Elting LS, Bodey GP. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplantation (In press). Please note: This will be published in September, 1995.

    Google Scholar 

  108. Whimbey E, Champlin R, Englund J, Couch R, Mirza N, Lewis V, Goodrich J, Bodey GP. 1994. Hi-dose short-duration aerosolized ribavirin for respiratory syncytial virus (RSV) disease in adult BMT recipients. In: Program and Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Florida, 1994.

    Google Scholar 

  109. Whimbey E, Couch R, Englund J, Andreeff M, Lewis V, Mirza N, Baxter B, Goodrich J, Bodey GP. Respiratory syncytial virus (RSV) pneumonia among hospitalized adult patients with leukemia. Clinical Infectious Diseases 21:376–379, 1995.

    Article  PubMed  CAS  Google Scholar 

  110. Wendt CH, Weisdorf DJ, Jordan MC, Balfour HH, Hertz MI. 1992. Parainfluenza virus respiratory infection after bone marrow transplantation. N Engl J Med 326:921–926.

    Article  PubMed  CAS  Google Scholar 

  111. Whimbey E, Vartivarian SE, Champlin RE, Elting LS, Luna M, Bodey GP. 1993. Parainfluenza virus infection in adult bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis 12:699–701.

    Article  PubMed  CAS  Google Scholar 

  112. Shields AF, Hackman RC, Fife KH, Corey L, Meyers J. 1985. Adenovirus infections in patients undergoing bone marrow transplantation. N Engl J Med 312:529–533.

    Article  PubMed  CAS  Google Scholar 

  113. Mirza N, Whimbey E, Champlin R, Goodrich J, Couch R, Vartivarian S, Bodey G. 1993. Adenovirus infections in adult bone marrow transplant recipients. In: Program and Abstracts of the 33rd Infectious Disease Conference on Antimicrobial Agents and Chemotherapy, New Orleans, Louisiana, 1993.

    Google Scholar 

  114. Rosen P, Armstrong D, Ramos C. 1972. Pneumocystis carinii pneumonia: A clinicopathologic study of twenty patients with neoplastic diseases. Am J Med 53: 428–436.

    Article  PubMed  CAS  Google Scholar 

  115. Hughes WT, Price RA, Kim H-K, Coburn TP, Grigsby D, Feldman S. 1973. Pneumocystis carinii pneumonitis in children with malignancies. J Pediatr 82:404–415.

    Article  PubMed  CAS  Google Scholar 

  116. Walzer PD, Perl DP, Krogstad DJ, Rawson PG, Schultz MG. 1974. Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80:83–93.

    PubMed  CAS  Google Scholar 

  117. Luna MA, Cleary KR. 1989. Spectrum of pathologic manifestations of Pneumocystis carinii pneumonia in patients with neoplastic diseases. Semin Diagn Pathol 6:262–272.

    PubMed  CAS  Google Scholar 

  118. Singer C, Armstrong D, Rosen PP, Walzer PD, Yu B. 1979. Diffuse pulmonary infiltrates in immunosuppressed patients: Prospective study of 80 cases. Am J Med 66:110–120.

    Article  PubMed  CAS  Google Scholar 

  119. Goodell B, Jacobs JB, Powell RD, DeVita VT. 1979. Pneumocystis carinii: The spectrum of diffuse interstitial pneumonia in patients with neoplastic diseases. Ann Intern Med 72:337–340.

    Google Scholar 

  120. Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AOS. 1991. Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409.

    PubMed  CAS  Google Scholar 

  121. Slivka A, Wen PY, Shea WM, Leoffler JS. 1993. Pneumocystis carinii pneumonia during steroid taper in patients with primary brain tumors. Am J Med 94:216–219.

    Article  PubMed  CAS  Google Scholar 

  122. Singer C, Armstrong D, Rosen PP, Schottenfeld D. 1975. Pneumocystis carinii pneumonia: A cluster of eleven cases. Ann Intern Med 82:772–777.

    PubMed  CAS  Google Scholar 

  123. Sepkowitz KA, Brown AE, Telzak EE, Gottlieb S, Armstrong D. 1992. Pneumocystis carinii pneumonia among patients without AIDS at a cancer hospital. JAMA 267:832–836.

    Article  PubMed  CAS  Google Scholar 

  124. Varthalitis I, Aoun M, Daneau D, Meunier F. 1993. Pneumocystis carinii pneumonia in patients with cancer. An increasing incidence. Cancer 71:481–485.

    Article  PubMed  CAS  Google Scholar 

  125. Kovacs JA, Hiemenz JW, Macher AM, Stover D, Murray HW, Shelhamer J, Lane C, Urmacher C, Honig C, Longo DL, Parker MM, Natanson C, Parillo JE, Fauci AS, Pizzo PA, Masur H. 1984. Pneumocystis carinii pneumonia: A comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies. Ann Intern Med 100:663–671.

    PubMed  CAS  Google Scholar 

  126. Masur H, Gill VJ, Ognibene FP, Shelhamer J, Godwin C, Kovacs JA. 1988. Diagnosis of Pneumocystis pneumonia by induced sputum technique in patients without the acquired immunodeficiency syndrome. Ann Intern Med 109: 755–756.

    PubMed  CAS  Google Scholar 

  127. Hughes WT, Kuhn S, Chaudhary S, Feldman S, Verzosa M, Aur RJA, Pratt C, George SL. 1977. Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297:1419–1426.

    Article  PubMed  CAS  Google Scholar 

  128. Sattler FR, Cowan R, Nielsen DM, Ruskin J. 1988. Trimethoprim-sulfamethoxazole compared with pentamidine for treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: A prospective, noncrossover study. Ann Intern Med 109:280–287.

    PubMed  CAS  Google Scholar 

  129. Carey RM, Kimball AC, Armstrong D, Lieberman PH. 1973. Toxoplasmosis: Clinical experiences in a cancer hospital. Am J Med 54:30–38.

    Article  PubMed  CAS  Google Scholar 

  130. Vietzke WM, Gelderman AH, Grimley PM, Valsamis MP. 1968. Toxoplasmosis complicating malignancy: Experience at the National Cancer Institute. Cancer 21:816–827.

    Article  PubMed  CAS  Google Scholar 

  131. Ruskin J, Remington JS. 1976. Toxoplasmosis in the compromised host. Ann Intern Med 84:193–199.

    PubMed  CAS  Google Scholar 

  132. Catterall JR, Hofflin JM, Remington JS. 1986. Pulmonary toxoplasmosis. Am Rev Respir Dis 133:704–705.

    PubMed  CAS  Google Scholar 

  133. Pomeroy C, Filice GA. 1992. Pulmonary toxoplasmosis: A review. Clin Infect Dis 14:863–870.

    Article  PubMed  CAS  Google Scholar 

  134. Luft BJ, Remington JS. 1985. Toxoplasmosis of the central nervous system. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases, Vol 6. New York: McGraw-Hill, pp 315–358.

    Google Scholar 

  135. Deroin F, Devergie A, Auber P, et al. 1992. Toxoplasmosis in bone marrow transplant recipients: report of seven cases and review. Clin Infect Dis 15:267–270.

    Article  Google Scholar 

  136. Israelski DM, Remington JS. 1993. Toxoplasmosis in patients with cancer. Clin Infect Dis (Suppl 2):S423–S435.

    Article  Google Scholar 

  137. DeVault Jr, King JW, Rohr MS, Landreneau MD, Brown ST III, McDonald JC. 1990. Opportunistic infections with Strongyloides stercoralis in renal transplantation. Rev Infect Dis 12:653–671.

    Article  PubMed  Google Scholar 

  138. Igra-Siegman Y, Kapila R, Sen P, Kaminski ZC, Louria DB. 1981. Syndrome of hyperinfection with Strongyloides stercoralis. Rev Infect Dis 3:397–407.

    Article  PubMed  CAS  Google Scholar 

  139. Pennington JE, Feldman NT. 1977. Pulmonary infiltrates and fevers in patients with hematologic malignancy: Assessment of transbronchial biopsy. Am J Med 62:581–587.

    Article  PubMed  CAS  Google Scholar 

  140. McCabe RE, Brooks RG, Mark JBD, Remington JS. 1985. Open lung biopsy in patients with acute leukemia. Am J Med 78:609–616.

    Article  PubMed  CAS  Google Scholar 

  141. Cockerill FR, Wilson WR, Carpenter HA, Smith TF, Rosenow ED. 1985. Open lung biopsy in immunocompromised patients. Arch Intern Med 145:1398–1404.

    Article  PubMed  Google Scholar 

  142. Schaffner A, Douglas H, Braude A. 1982. Selective protection against Candida by mononuclear and against Mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 69:617–619.

    Article  PubMed  CAS  Google Scholar 

  143. Bodey GP, Vartivarian S. 1989. Aspergillosis. Eur J Clin Microbiol Infect Dis 8:413–437.

    Article  PubMed  CAS  Google Scholar 

  144. Bodey GP. 1992. Hematogenous and major organ candidiasis. In: Bodey GP, ed Candidiasis: Pathogenesis, Diagnosis, and Treatment. New York: Raven Press, pp 279–329.

    Google Scholar 

Download references

Authors
  1. Estella Whimbey
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Goodrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gerald P. Bodey
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Service de Medecine Interne et Laboratoire d’Inverstigation, Clinique, H.J. Tagnon, Institut Jules Bordet, Centre des Tumeurs de L’Universite, Libre de Bruxelles, Belgium

    Jean Klastersky

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Kluwer Academic Publishers

About this chapter

Cite this chapter

Whimbey, E., Goodrich, J., Bodey, G.P. (1995). Pneumonia in cancer patients. In: Klastersky, J. (eds) Infectious Complications of Cancer. Cancer Treatment and Research, vol 79. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1239-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-1239-0_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-8527-4

  • Online ISBN: 978-1-4613-1239-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation